C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation

被引:162
作者
Watanabe, T
Takeishi, Y
Hirono, O
Itoh, M
Matsui, M
Nakamura, K
Tamada, Y
Kubota, I
机构
[1] Yamagata Univ, Sch Med, Dept Internal Med 4, Yamagata 9909585, Japan
[2] Okitama Publ Gen Hosp, Dept Internal Med, Yamagata, Japan
关键词
atrial fibrillation; C-reactive protein; atrial remodeling;
D O I
10.1007/s00380-004-0800-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been poorly understood whether inflammation may contribute to atrial structural remodeling and increase the propensity for atrial fibrillation (AF) to persist. We investigated the relationship between C-reactive protein (CRP) elevation and the development of atrial remodeling in AF. The study population comprised 50 consecutive paroxysmal AF (PAF) patients and 50 control patients without AF. All patients underwent echocardiography, and high-sensitivity CRP was routinely measured. C-Reactive protein was significantly higher in the patients with PAF than control patients (0.231 +/- 0.176mg/dl vs 0.055 +/- 0.041 mg/dl, P +/-< 0.001). Other predictors of elevated CRP included left ventricular mass (P < 0.05), left ventricular end-systolic diameter (P < 0.05), and left atrial (LA) diameter ( P < 0.001). In a multivariate analysis, only CRP and LA diameter were independent predictors of PAF. Elevated CRP levels correlated with LA diameter (r = 0.489, P < 0.001). Left atrial diameter was increased in PAF patients compared with control patients ( P < 0.001). We found that a longer duration of AF is associated with higher CRP levels and a larger LA diameter (duration < 30 days: CRP 0.166 +/- 0.139 mg/dl, LA diameter 38.4 +/- 8.0 mm; duration < 30 days: CRP 0.345 +/- 0.181mg/dl, LA diameter 45.6 +/- 6.6mm; P < 0.001). In conclusion, longer AF duration is associated with CRP elevation and atrial structural remodeling, as approximated by larger LA diameter. However, CRP elevation, while correlating with LA diameter, was not an independent predictor of atrial structural remodeling. Thus, it remains unclear whether CRP and the inflammatory state are contributory to LA remodeling or whether LA remodeling or AF induces elevation in CRP and inflammation.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 17 条
[1]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[2]  
Bruins P, 1997, CIRCULATION, V96, P3542
[3]   C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].
Chung, MK ;
Martin, DO ;
Sprecher, D ;
Wazni, O ;
Kanderian, A ;
Carnes, CA ;
Bauer, JA ;
Tchou, PJ ;
Niebauer, MJ ;
Natale, A ;
Van Wagoner, DR .
CIRCULATION, 2001, 104 (24) :2886-2891
[4]   C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation [J].
Dernellis, J ;
Panaretou, M .
ACTA CARDIOLOGICA, 2001, 56 (06) :375-380
[5]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618
[6]   CARDIAC BIOPSY IN PATIENTS WITH PRIMARY ATRIAL-FIBRILLATION - HISTOLOGIC EVIDENCE OF OCCULT MYOCARDIAL DISEASES [J].
FRUSTACI, A ;
CALDARULO, M ;
BUFFON, A ;
BELLOCCI, F ;
FENICI, R ;
MELINA, D .
CHEST, 1991, 100 (02) :303-306
[7]   Histological substrate of atrial biopsies in patients with lone atrial fibrillation [J].
Frustaci, A ;
Chimenti, C ;
Bellocci, F ;
Morgante, E ;
Russo, MA ;
Maseri, A .
CIRCULATION, 1997, 96 (04) :1180-1184
[8]   The role of nonpharmacologic therapies for the treatment of atrial fibrillation [J].
Guerra, PG ;
Lesh, MD .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (03) :450-460
[9]   C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men -: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 [J].
Koenig, W ;
Sund, M ;
Fröhlich, M ;
Fischer, HG ;
Löwel, H ;
Döring, A ;
Hutchinson, WL ;
Pepys, MB .
CIRCULATION, 1999, 99 (02) :237-242
[10]   C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction [J].
Lagrand, WK ;
Niessen, HWM ;
Wolbink, GJ ;
Jaspars, LH ;
Visser, CA ;
Verheugt, FWA ;
Meijer, CJLM ;
Hack, CE .
CIRCULATION, 1997, 95 (01) :97-103